Hawthorn for Blood Clots: What the Evidence Shows

Key takeaways on hawthorn and blood clots

Hawthorn is commonly used as a herbal supplement for cardiovascular support, yet direct high-quality evidence for dissolving or preventing blood clots in humans is limited. Potential mechanisms include mild antioxidant and anti-inflammatory actions, and modest effects on blood pressure and blood flow, but hawthorn is not a proven treatment for thrombotic conditions. If you are considering hawthorn while being treated for or at risk of blood clots, consult a clinician, because herbal components can interact with anticoagulant or antiplatelet medications and may affect bleeding risk. The following explains what is known, what is uncertain, and how to approach discussions with your clinician.

What hawthorn is and how it is used

Hawthorn (Crataegus spp.) refers to a group of shrubs and small trees in the rose family, whose leaves, flowers, and berries have a long history of use in traditional medicine, particularly in European and North American herbal practice. Commercial preparations typically use extracts from the berries, leaves, or flowers and are standardized to varying degrees depending on the intended application. Historically, hawthorn has been employed to support heart function, manage mild hypertension, and alleviate symptoms related to mild heart failure, and this background informs many modern uses. Today, hawthorn is widely sold as a dietary supplement and often marketed for general cardiovascular wellness, including circulation and blood pressure support, even though rigorous confirmation of those effects in diverse patient populations remains an active area of study.

How blood clots form and why they matter

Blood clotting, or hemostasis, is a tightly regulated process that stops bleeding after injury through a coordinated sequence involving platelets, clotting factors, and fibrin mesh. When clots form inside blood vessels without an external injury, or when they fail to resolve appropriately, they can obstruct flow and contribute to events such as deep vein thrombosis (DVT), pulmonary embolism (PE), and ischemic stroke. Arterial clots often underlie myocardial infarction and stroke, while venous clotting is more commonly associated with DVT and PE. Risk factors include prolonged immobility, surgery, certain medical conditions, medications, and inherited or acquired thrombophilias. Because both clot formation and its prevention involve complex pathways, interventions that influence platelets, coagulation factors, or vessel function can alter clot risk, whether intentionally as prescription therapy or incidentally through supplements or herbal products.

Plausible mechanisms by which hawthorn could affect clotting

Antioxidant and anti-inflammatory properties

Hawthorn contains polyphenols, oligomeric procyanidins, quercetin, and related compounds that have demonstrated antioxidant and anti-inflammatory activity in laboratory and animal studies. These properties are biologically relevant to vascular health, since oxidative stress and inflammation contribute to endothelial dysfunction and atherosclerosis. By reducing oxidative stress and modulating inflammatory signaling, hawthorn may support endothelial function and improve blood flow in certain models, but direct evidence showing meaningful antithrombotic effects in humans is not yet available.

Effects on blood pressure and peripheral circulation

Several clinical studies indicate that hawthorn extracts can produce modest reductions in blood pressure and improvements in symptoms of mild chronic heart failure, potentially through vasodilation and mild inotropic effects. Improved blood flow and reduced cardiac workload may indirectly influence clot risk in people with heart failure–related stasis, a recognized contributor to thrombus formation. However, these circulatory effects are generally mild and variable, and they do not equate to a clinically significant antithrombotic impact in the absence of robust human data demonstrating reduced clot incidence.

Potential interactions with anticoagulant pathways

Laboratory and animal research suggest that certain hawthorn constituents may modestly influence pathways involved in coagulation and platelet function, but such findings do not establish meaningful clinical effects in patients. Because many of these pathways are targeted by prescription anticoagulants and antiplatelet agents, any theoretical interaction warrants careful evaluation in the context of concurrent medications. Patients using drugs such as warfarin, direct oral anticoagulants, aspirin, or clopidogrel should be monitored closely when using hawthorn, particularly if bleeding or clotting abnormalities occur.

What the evidence currently shows

Most human studies of hawthorn have focused on blood pressure, heart failure symptoms, and surrogate cardiovascular markers, with relatively few investigations specifically addressing thrombotic outcomes. Available trials are often small, short in duration, or lack rigorous controls, limiting conclusions about hawthorn’s role in clot prevention or resolution. No large, high-quality randomized trials have established hawthorn as an effective treatment for deep vein thrombosis, pulmonary embolism, or arterial thrombotic events. Consequently, healthcare professionals typically do not recommend hawthorn as a primary or adjunctive therapy for thrombotic conditions, and people with clotting disorders or those at high risk should rely on evidence-based treatments under clinician supervision.

Practical considerations and safety guidance

Potential side effects and cautions

When used appropriately, hawthorn is generally well tolerated, but side effects can include dizziness, lightheadedness, gastrointestinal discomfort, and palpitations. Because of its cardiovascular effects, it may interact with medications that lower blood pressure or heart rate. People with persistent or severe cardiac conditions should use hawthorn only under professional oversight. Additionally, individuals preparing for surgery or dental procedures should inform their clinician if they are using hawthorn, due to possible bleeding implications.

Drug–herb interactions to watch for

• Warfarin and other anticoagulants: theoretical increased bleeding risk; close INR monitoring recommended.
• Antiplatelet agents (e.g., aspirin, clopidogrel): potential additive effects on bleeding.
• Antihypertensive medications: possible additive blood pressure–lowering effect, requiring dose adjustments.
• Digoxin and certain heart rhythm medications: additive effects on heart rate and contractility may occur.

Who should avoid or be especially cautious with hawthorn

Individuals with known bleeding disorders, scheduled surgeries, or those using anticoagulants or antiplatelet therapy should exercise particular caution. Pregnant and breastfeeding people should generally avoid hawthorn due to insufficient safety data, and those with severe heart block or other conduction abnormalities should not use hawthorn without direct cardiology supervision. Because herbal products like hawthorn are not regulated as pharmaceuticals, variability in composition and dosing can occur, which further underscores the importance of professional guidance.

How to discuss hawthorn safely with your clinician

If you are considering hawthorn for cardiovascular support while being treated for or at risk of blood clots, prepare for your clinician visit by listing all prescription medications, over-the-counter drugs, and supplements you take, including doses and frequency. Ask your clinician about the evidence for hawthorn in your specific situation, potential interactions with your current therapies, and what monitoring (e.g., INR for warfarin) might be appropriate. Request clarification on symptoms that would warrant prompt medical attention, such as unusual bruising, prolonged bleeding, new swelling or pain in limbs, or signs of clot-related complications, and discuss when follow-up evaluation is needed.

Summary and bottom-line points

Bottom line

While hawthorn has a long history of use in heart health and may offer modest cardiovascular benefits, there is currently insufficient robust evidence to support its use specifically for preventing or treating blood clots. Its potential benefits must be weighed against possible interactions with medications and the availability of proven therapies. If you have concerns about clot risk or are considering hawthorn, work with your clinician to develop a safe, evidence-based plan tailored to your health needs.